Thomas d’Aquin Toni

602 total citations
21 papers, 454 citations indexed

About

Thomas d’Aquin Toni is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Thomas d’Aquin Toni has authored 21 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 17 papers in Virology and 4 papers in Epidemiology. Recurrent topics in Thomas d’Aquin Toni's work include HIV/AIDS Research and Interventions (19 papers), HIV Research and Treatment (17 papers) and HIV/AIDS drug development and treatment (17 papers). Thomas d’Aquin Toni is often cited by papers focused on HIV/AIDS Research and Interventions (19 papers), HIV Research and Treatment (17 papers) and HIV/AIDS drug development and treatment (17 papers). Thomas d’Aquin Toni collaborates with scholars based in Ivory Coast, France and Canada. Thomas d’Aquin Toni's co-authors include Bluma Brenner, Mark A. Wainberg, Michel Ntemgwa, Ricardo Camacho, Bernard Masquelier, Hervé Fleury, Maureen Oliveira, Roger Salamon, Daniela Moïsi and Eugene L. Asahchop and has published in prestigious journals such as PLoS ONE, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Thomas d’Aquin Toni

20 papers receiving 440 citations

Peers

Countries citing papers authored by Thomas d’Aquin Toni

Since Specialization

Citations

This map shows the geographic impact of Thomas d’Aquin Toni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas d’Aquin Toni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas d’Aquin Toni more than expected).

Fields of papers citing papers by Thomas d’Aquin Toni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas d’Aquin Toni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas d’Aquin Toni. The network helps show where Thomas d’Aquin Toni may publish in the future.

Co-authorship network of co-authors of Thomas d’Aquin Toni

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas d’Aquin Toni. A scholar is included among the top collaborators of Thomas d’Aquin Toni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas d’Aquin Toni. Thomas d’Aquin Toni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Higher risk of mortality in HIV-HBV co-infected patients from sub-Saharan Africa is observed at lower CD4⁺ cell counts 2021 ·Antiviral Therapy ·Gérard Menan Kouamé, Delphine Gabillard, Raoul Moh, Anani Badjé, (unknown), Arlette Emième, Sarah Maylin, Thomas d’Aquin Toni, Hervé Menan, Fabien Zoulim, Christine Danel, Xavier Anglaret, Serge Eholié, Karine Lacombe, Anders Boyd	4
2	Model-based cost-effectiveness estimates of testing strategies for diagnosing hepatitis C virus infection in Central and Western Africa 2020 ·PLoS ONE ·(unknown), Gilles Hejblum, Richard Njouom, Coumba Touré Kane, Thomas d’Aquin Toni, Raoul Moh, (unknown), Nicolas Rouveau, Alain Attia, Karine Lacombe	15
3	Determination of reverse transcriptase inhibitor resistance mutations in HIV-1 infected children in Côte d’Ivoire 2020 ·Genome ·(unknown), (unknown), Thomas d’Aquin Toni, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	3
4	Mesure de l’ARN VIH-1 et du taux de lymphocytes TCD4 dans le suivi du traitement antirétroviral de patients infectés par le VIH en Côte d’Ivoire 2019 ·International Journal of Biological and Chemical Sciences ·(unknown), Thomas d’Aquin Toni, Timothée Ouassa, Hervé Menan, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Eric Nerrienet, G Raguin, Christine Rouzioux, Dagui Monnet	0
5	Evaluation of dried blood spot diagnosis using HIV1-DNA and HIV1-RNA Biocentric assays in infants in Abidjan, Côte d’Ivoire. The Pedi-Test DBS ANRS 12183 Study 2013 ·Journal of Virological Methods ·(unknown), Thomas d’Aquin Toni, Sophie Desmonde, Clarisse Amani‐Bosse, (unknown), (unknown), Hervé Menan, Marguerite Timité‐Konan, Valériane Leroy, Christine Rouzioux	8
6	Comparison of Early CD4 T-Cell Count in HIV-1 Seroconverters in Côte d'Ivoire and France: The ANRS PRIMO-CI and SEROCO Cohorts 2010 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·(unknown), Rodolphe Thiébaut, Faroudy Boufassa, (unknown), Karen Malateste, Rémonie Seng, Thomas d’Aquin Toni, André Inwoley, Christine Rouzioux, Albert Minga, Xavier Anglaret, Laurence Meyer	10
7	Tissue culture drug resistance analysis of a novel HIV-1 protease inhibitor termed PL-100 in non-B HIV-1 subtypes 2010 ·Antiviral Research ·Eugene L. Asahchop, Maureen Oliveira, Bluma Brenner, Jorge Martínez-Cajas, Thomas d’Aquin Toni, Michel Ntemgwa, Daniela Moïsi, (unknown), Brent R. Stranix, Cécile Tremblay, Mark A. Wainberg	1
8	Occult HBV infection in untreated HIV-infected adults in Côte d'Ivoire 2010 ·Antiviral Therapy ·Thérèse N’Dri-Yoman, Xavier Anglaret, Eugène Messou, Alain Attia, (unknown), Thomas d’Aquin Toni, (unknown), Catherine Seyler, Delphine Gabillard, Naomi Wakasugi, Serge Eholié, Christine Danel	37
9	Characterization of the E138K Resistance Mutation in HIV-1 Reverse Transcriptase Conferring Susceptibility to Etravirine in B and Non-B HIV-1 Subtypes 2010 ·Antimicrobial Agents and Chemotherapy ·Eugene L. Asahchop, Maureen Oliveira, Mark A. Wainberg, Bluma Brenner, Daniela Moïsi, Thomas d’Aquin Toni, Cécile Tremblay	48
10	Medium-Term Probability of Success of Antiretroviral Treatment after Early Warning Signs of Treatment Failure in West African Adults 2009 ·AIDS Research and Human Retroviruses ·Christine Danel, Delphine Gabillard, André Inwoley, Marie‐Laure Chaix, Thomas d’Aquin Toni, Raoul Moh, Eugène Messou, E. Bissagnené, Roger Salamon, Serge Eholié, Xavier Anglaret	7
11	Low Prevalence of HIV Type 1 Drug Resistance Mutations in Untreated, Recently Infected Patients from Burkina Faso, Côte d'Ivoire, Senegal, Thailand, and Vietnam: The ANRS 12134 Study 2009 ·AIDS Research and Human Retroviruses ·Ahidjo Ayouba, (unknown), Janin Nouhin, Laurence Vergne, Avelin F. Aghokeng, Nicole Ngo‐Giang‐Huong, Halimatou Diop‐Ndiaye, Coumba Touré Kane, Diane Valéa, François Rouet, (unknown), Thomas d’Aquin Toni, Eric Nerrienet, Eitel Mpoudi Ngole, Éric Delaporte, Dominique Costagliola, Martine Peeters, Marie‐Laure Chaix	44
12	Near Full-Length Genomic Analysis of a Novel Subtype A1/C Recombinant HIV Type 1 Isolate from Canada 2008 ·AIDS Research and Human Retroviruses ·Michel Ntemgwa, Thomas d’Aquin Toni, Bluma Brenner, Jean‐Pierre Routy, Daniela Moïsi, Maureen Oliveira, Mark A. Wainberg	3
13	Two-Months-off, Four-Months-on Antiretroviral Regimen Increases the Risk of Resistance, Compared with Continuous Therapy: A Randomized Trial Involving West African Adults 2008 ·The Journal of Infectious Diseases ·Christine Danel, Raoul Moh, Marie‐Laure Chaix, Delphine Gabillard, (unknown), (unknown), Thomas d’Aquin Toni, (unknown), Christine Rouzioux, E. Bissagnené, Roger Salamon, Xavier Anglaret, (unknown)	31
14	Nucleoside and Nucleotide Analogs Select in Culture for Different Patterns of Drug Resistance in Human Immunodeficiency Virus Types 1 and 2 2008 ·Antimicrobial Agents and Chemotherapy ·Michel Ntemgwa, Thomas d’Aquin Toni, Bluma Brenner, Maureen Oliveira, Eugene L. Asahchop, Daniela Moïsi, Mark A. Wainberg	23
15	HIV-1 Antiretroviral Drug Resistance in Recently Infected Patients in Abidjan, Côte d'Ivoire: A 4-Year Survey, 2002–2006 2007 ·AIDS Research and Human Retroviruses ·Thomas d’Aquin Toni, Bernard Masquelier, Albert Minga, Xavier Anglaret, Christine Danel, (unknown), (unknown), François Dabis, Roger Salamon, Hervé Fleury, (unknown)	29
16	Susceptibility to Antiretroviral Drugs of CRF01_AE, CRF02_AG, and Subtype C Viruses from Untreated Patients of Africa and Asia: Comparative Genotypic and Phenotypic Data 2006 ·AIDS Research and Human Retroviruses ·Hervé Fleury, Thomas d’Aquin Toni, (unknown), Phạm Văn Hưng, Alaka Deshpande, Patrícia Recordon-Pinson, (unknown), Estibaliz Lazaro, Valérie Jauvin, (unknown), Sophie Lebel‐Binay, Arnaud Chéret, Bernard Masquelier	32
17	Presence of CRF09_cpx and Complex CRF02_AG/CRF09_cpx Recombinant HIV Type 1 Strains in Côte d'Ivoire, West Africa 2005 ·AIDS Research and Human Retroviruses ·Thomas d’Aquin Toni, Christiane Adjé-Touré, Nicole Vidal, Albert Minga, Charlotte Huët, (unknown), Patrícia Recordon-Pinson, Bernard Masquelier, Monica Nolan, John N. Nkengasong, Hervé Fleury, Éric Delaporte, Martine Peeters	12
18	Characterization of Nevirapine (NVP) Resistance Mutations and HIV Type 1 Subtype in Women from Abidjan (Côte d'Ivoire) After NVP Single-Dose Prophylaxis of HIV Type 1 Mother-to-Child Transmission 2005 ·AIDS Research and Human Retroviruses ·Thomas d’Aquin Toni, Bernard Masquelier, Estibaliz Lazaro, (unknown), (unknown), (unknown), Kouakou Kouadio, (unknown), (unknown), (unknown), (unknown), (unknown), Patrícia Recordon-Pinson, (unknown), Hervé Fleury	20
19	Presence of Key Drug Resistance Mutations in Isolates from Untreated Patients of Abidjan, Côte d'Ivoire: ANRS 1257 Study 2003 ·AIDS Research and Human Retroviruses ·Thomas d’Aquin Toni, Patrícia Recordon-Pinson, Albert Minga, Didier Koumavi Ekouévi, Dominique Bonard, Laurence Béquet, Charlotte Huët, (unknown), François Rouet, François Dabis, Marie‐Edith Lafon, Roger Salamon, Bernard Masquelier, Hervé Fleury	34
20	Primary HIV-1 drug resistance in Abidjan (Côte d'Ivoire): a genotypic and phenotypic study 2002 ·AIDS ·Thomas d’Aquin Toni, Bernard Masquelier, Dominique Bonard, Muriel Faure, Charlotte Huët, Anne Caumont, Pierre Roques, François Dabis, Roger Salamon, Hervé Fleury	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact